12 research outputs found

    Managing thyroid dysfunction in selected special situations

    Get PDF
    Managing thyroid dysfunction is simple at first glance, the idea is to bring hormone levels in the euthyroid range, treat with antithyroid drugs, radio-iodine or surgery if toxic and replace with thyroxine or T3 if hypothyroid. Complexities arise when there are coexisting conditions that affect the thyroid or are affected by thyroid dysfunction and this review will deal with the special situations that need care when correcting thyroid hormone levels

    Ultrasound diagnosis of cephalopagus conjoined twin pregnancy at 29 weeks

    Get PDF
    The authors report a case of a cephalopagus conjoined twin that was diagnosed at 29 weeks of gestation despite the mother having had two ultrasounds done previously. The fetus had one head and face, fused thoraces, common umbilicus but had two pelvises and two sets of genitalia. The fetus had four normally formed legs and arms

    Prenatal diagnosis of Neu-Laxova syndrome: a case report

    Get PDF
    BACKGROUND: Neu-Laxova syndrome is a rare congenital abnormality involving multiple systems. We report a case of Neu-Laxova syndrome (NLS) diagnosed prenatally by ultrasound examination. CASE PRESENTATION: A 29-year-old gravida 3, para 2 woman was first seen in our antenatal clinic at 38 weeks' pregnancy. Except for the consanguinity and two previous abnormal stillborn babies her medical history was unremarkable. On ultrasound examination microcephaly, flat forehead, micrognathia, intrauterine growth restriction, generalized edema of the skin, hypoplastic chest, excessive soft tissue deposition of hands and feet, joint contractures and a penis without scrotal sacs were detected. She delivered a 2000 g male fetus. He died five minutes after delivery. Postmortem examination confirmed the diagnosis of Neu-Laxova syndrome. CONCLUSION: Because of the autosomal recessive inheritance of Neu-Laxova syndrome genetic counseling and early-serial ultrasound examination should be performed at risk families. Early diagnosis of the disease may offer termination of the pregnancy as an option

    The Asian Nuclear Medicine Board; Why Do We Need It?

    No full text
    No abstract availabl

    Pictorial essay of radiological features of benign intrathoracic masses

    No full text
    With increased exposure of patients to routine imaging, incidental benign intrathoracic masses are frequently recognized. Most have classical imaging features, which are pathognomonic for their benignity. The aim of this pictorial review is to educate the reader of radiological features of several types of intrathoracic masses. The masses are categorized based on their location/origin and are grouped into parenchymal, pleural, mediastinal, or bronchial. Thoracic wall masses that invade the thorax such as neurofibromas and lipomas are included as they may mimic intrathoracic masses. All examples are illustrated and include pulmonary hamartoma, pleural fibroma, sarcoidosis, bronchial carcinoid, and bronchoceles together with a variety of mediastinal cysts on plain radiographs, computed tomography (CT) and magnetic resonance imaging (MRI). Sometimes a multimodality approach would be needed to confirm the diagnosis in atypical cases. The study would include the incorporation of radionuclide studies and relevant discussion in a multidisciplinary setting

    Naja naja karachiensis Envenomation: Biochemical Parameters for Cardiac, Liver, and Renal Damage along with Their Neutralization by Medicinal Plants

    No full text
    Naja naja karachiensis envenomation was found to hit more drastically heart, liver, and kidneys. 400 μg/kg of venom-raised moderate serum levels of ALT (72±4.70 U/L, 0.1>P>0.05), AST (157±24.24 U/L, 0.1>P>0.05), urea (42±3.08 mg/dL, 0.05>P>0.02), creatinine (1.74±0.03 mg/dL, 0.01>P>0.001), CK-MB (21±1.5 U/L, 0.05>P>0.02), and LDH (2064±15.98 U/L, P<0.001) were injected in experimental rabbits. However, lethality was enhanced with 800 μg/kg of venom in terms of significant release of ALT (86±5.0 U/L, 0.05>P>0.02), AST (251±18.2 U/L, 0.01>P>0.001), urea (57.6±3.84 mg/dL, 0.02>P>0.01), creatinine (2.1±0.10 mg/dL, 0.02>P>0.01), CK-MB (77±11.22 U/L, 0.05>P>0.02), and LDH (2562±25.14 U/L, P≪0.001). Among twenty-eight tested medicinal plant extracts, only Stenolobium stans (L.) Seem was found the best antivenom (P>0.5) compared to the efficacy of standard antidote (ALT =52.5±3.51 U/L, AST =69.5±18.55 U/L, urea =31.5±0.50 mg/dL, creatinine =1.08±0.02 mg/dL, CK-MB =09±0.85 U/L, and LDH =763±6.01 U/L). Other plant extracts were proved less beneficial and partly neutralized the toxicities posed by cobra venom. However, it is essential in future to isolate and characterize bioactive compound(s) from Stenolobium stans (L.) Seem extract to overcome the complications of snake bite
    corecore